1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Lateral Flow Assay Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Lateral Flow Assay Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Use of Home-Based Assay Kits
5.2 Market Opportunities
- 5.2.1 Evolving Applications of Lateral Flow Assays
5.3 Future Trends
- 5.3.1 Smartphone Usage and Al Integration in Lateral Flow Immunoassay
5.4 Impact of Drivers and Restraints
6. North America Lateral Flow Assay Market Regional Analysis
6.1 North America Lateral Flow Assay Market Overview
6.2 North America Lateral Flow Assay Market Revenue 2020-2030 (US$ Million)
6.3 North America Lateral Flow Assay Market Forecast Analysis
7. North America Lateral Flow Assay Market Analysis – by Product Type
7.1 Kits & Reagents and Lateral Flow Readers
- 7.1.1 Overview
- 7.1.2 Kits & Reagents and Lateral Flow Readers: North America Lateral Flow Assay Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Lateral Flow Assay Market Analysis – by Technique
8.1 Sandwich Assay
- 8.1.1 Overview
- 8.1.2 Sandwich Assay: North America Lateral Flow Assay Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Competitive Assays
- 8.2.1 Overview
- 8.2.2 Competitive Assays: North America Lateral Flow Assay Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Multiplex Detection Assay
- 8.3.1 Overview
- 8.3.2 Multiplex Detection Assay: North America Lateral Flow Assay Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Lateral Flow Assay Market Analysis – by Test Type
9.1 Lateral Flow Immunoassay and Nucleic Acid Lateral Flow Assay
- 9.1.1 Overview
- 9.1.2 Multiplex Detection Assay: North America Lateral Flow Assay Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Lateral Flow Assay Market – North America Analysis
10.1 North America
- 10.1.1 North America Lateral Flow Assay Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.1.1.1 North America Lateral Flow Assay Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Lateral Flow Assay Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.1.1 US: North America Lateral Flow Assay Market Breakdown, by Product Type
- 10.1.1.1.2 US: North America Lateral Flow Assay Market Breakdown, by Technique
- 10.1.1.1.3 US: North America Lateral Flow Assay Market Breakdown, by Test Type
- 10.1.1.2 Canada:
North America Lateral Flow Assay Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.2.1 Canada: North America Lateral Flow Assay Market Breakdown, by Product Type
- 10.1.1.2.2 Canada: North America Lateral Flow Assay Market Breakdown, by Technique
- 10.1.1.2.3 Canada: North America Lateral Flow Assay Market Breakdown, by Test Type
- 10.1.1.3 Mexico :
North America Lateral Flow Assay Market – Revenue and Forecast to 2030 (US$ Million)
- 10.1.1.3.1 Mexico : North America Lateral Flow Assay Market Breakdown, by Product Type
- 10.1.1.3.2 Mexico : North America Lateral Flow Assay Market Breakdown, by Technique
- 10.1.1.3.3 Mexico : North America Lateral Flow Assay Market Breakdown, by Test Type
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Lateral Flow Assay Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Becton Dickinson and Co
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 bioMerieux SA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Bio-Rad Laboratories Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 F. Hoffmann-La Roche Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Hologic Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Merck KGaA
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 PerkinElmer Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 QIAGEN NV
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 QuidelOrtho Corp
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Siemens Healthineers AG
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Thermo Fisher Scientific Inc
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
14. Appendix
14.1 About Business Market Insights